LID.L Regulatory News (LID)

26 Feb 2008 07:00

For immediate release 26h February 2008 LIDCO GROUP PLC New product release - LiDCOview Pro

LiDCO, the UK based, AIM-quoted cardiovascular monitoring company, today announces the launch of its new data viewing and analysis software product LiDCOview Pro.

LiDCOview Pro has been developed as a PC based complementary software tool for LiDCOplus Monitor users. LiDCOview Pro software is designed to display historical hemodynamic data recorded by the LiDCOplus monitor. Clinical research, auditing, training and information sharing are all enhanced by the ability to rapidly convert beat-to-beat data into visual displays and reports.

LiDCOview Pro can display up to 24 hours at a time of hemodynamic data and has built in navigation tools to make finding data of interest very easy. The software also has, for the first time ever, a display of fluid responsiveness parameters showing relevant trends. Analysis and reporting of the data can be made to generate hourly observation reports. Likewise, audits of the data to determine if specific targets have been met, can be generated. LiDCO expect one of its main uses will be to audit the success of early goal directed therapy, through use of the LiDCOplus Monitor, which has been shown to dramatically reduce complications and length of stay.

Terry O'Brien, CEO of LiDCO commented: "LiDCOview Pro is a valuable addition to the growing LiDCO product family. Complex data can now be analysed and the achievement of therapeutic goals assessed by all staff with access to an ordinary computer and our software. "

For more information please contact:

LiDCO Group Plc Tel: +44 (0)20 7749 1500

Terry O'Brien - Chief Executive Theresa Wallis - Non-Executive Chairman

Buchanan Communications Tel: +44 (0)20 7466 5000 Tim Anderson, James Strong Notes for EditorsAbout LiDCO Group Plc

LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO's technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. For more information please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London and its current products are:

* LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume (PPV% and SVV%).

* LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner.

* LiDCOview is designed as a graphical display of historical LiDCOplus hemodynamic data. LiDCOview provides both the clinical researcher and the routine user with easy to view beat-to-beat hemodynamic data that was collected with the LiDCOplus.. LiDCOviewSE is the standard version of this tool and is available for free, allowing anyone to download and access data from the LiDCOplus. LiDCOviewPRO is the Professional version, allowing users to analyse, export and report the LiDCOplus data. A free trial of LiDCOviewPRO is available for evaluation purposes prior to purchase.

* LiDCOlive - software product in development for the remote display of hemodynamic monitoring parameters derived through use of the LiDCOplus monitor.

Distribution Network:

The Company has now achieved registration of its products in 14 markets in Europe, the USA, Brazil, South Korea and Japan. It sells direct in the UK and USA, and elsewhere through a worldwide network of speciality critical care and anesthesia distributors.